Cargando…
Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy
Retinal oxidative damage, associated with an ATP-binding cassette, sub-family A, member 4, also known as ABCA4 gene mutation, has been implicated as a major underlying mechanism for Stargardt disease/fundus flavimaculatus (STG/FF). Recent findings indicate that saffron carotenoid constituents crocin...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835540/ https://www.ncbi.nlm.nih.gov/pubmed/31618812 http://dx.doi.org/10.3390/nu11102461 |
_version_ | 1783466696394145792 |
---|---|
author | Piccardi, Marco Fadda, Antonello Martelli, Francesco Marangoni, Dario Magli, Adriano Minnella, Angelo M. Bertelli, Matteo Di Marco, Stefano Bisti, Silvia Falsini, Benedetto |
author_facet | Piccardi, Marco Fadda, Antonello Martelli, Francesco Marangoni, Dario Magli, Adriano Minnella, Angelo M. Bertelli, Matteo Di Marco, Stefano Bisti, Silvia Falsini, Benedetto |
author_sort | Piccardi, Marco |
collection | PubMed |
description | Retinal oxidative damage, associated with an ATP-binding cassette, sub-family A, member 4, also known as ABCA4 gene mutation, has been implicated as a major underlying mechanism for Stargardt disease/fundus flavimaculatus (STG/FF). Recent findings indicate that saffron carotenoid constituents crocins and crocetin may counteract retinal oxidative damage, inflammation and protect retinal cells from apoptosis. This pilot study aimed to evaluate central retinal function following saffron supplementation in STG/FF patients carrying ABCA4 mutations. Methods: in a randomized, double-blind, placebo-controlled study (clinicaltrials.gov: NCT01278277), 31 patients with ABCA4-related STG/FF and a visual acuity >0.25 were randomly assigned to assume oral saffron (20 mg) or placebo over a six month period and then reverted to P or S for a further six month period. Full ophthalmic examinations, as well as central 18° focal electroretinogram (fERG) recordings, were performed at baseline and after six months of either saffron or placebo. The fERG fundamental harmonic component was isolated by Fourier analysis. Main outcome measures were fERG amplitude (in µV) and phase (in degrees). The secondary outcome measure was visual acuity. Results: supplement was well tolerated by all patients throughout follow-up. After saffron, fERG amplitude was unchanged; after placebo, amplitude tended to decrease from baseline (mean change: −0.18 log µV, p < 0.05). Reverting the treatments, amplitude did not change significantly. fERG phase and visual acuity were unchanged throughout follow-up. Conclusions: short-term saffron supplementation was well tolerated and had no detrimental effects on the electroretinographic responses of the central retina and visual acuity. The current findings warrant further long-term clinical trials to assess the efficacy of saffron supplementation in slowing down the progression of central retinal dysfunction in ABCA4-related STG/FF. |
format | Online Article Text |
id | pubmed-6835540 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68355402019-11-25 Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy Piccardi, Marco Fadda, Antonello Martelli, Francesco Marangoni, Dario Magli, Adriano Minnella, Angelo M. Bertelli, Matteo Di Marco, Stefano Bisti, Silvia Falsini, Benedetto Nutrients Brief Report Retinal oxidative damage, associated with an ATP-binding cassette, sub-family A, member 4, also known as ABCA4 gene mutation, has been implicated as a major underlying mechanism for Stargardt disease/fundus flavimaculatus (STG/FF). Recent findings indicate that saffron carotenoid constituents crocins and crocetin may counteract retinal oxidative damage, inflammation and protect retinal cells from apoptosis. This pilot study aimed to evaluate central retinal function following saffron supplementation in STG/FF patients carrying ABCA4 mutations. Methods: in a randomized, double-blind, placebo-controlled study (clinicaltrials.gov: NCT01278277), 31 patients with ABCA4-related STG/FF and a visual acuity >0.25 were randomly assigned to assume oral saffron (20 mg) or placebo over a six month period and then reverted to P or S for a further six month period. Full ophthalmic examinations, as well as central 18° focal electroretinogram (fERG) recordings, were performed at baseline and after six months of either saffron or placebo. The fERG fundamental harmonic component was isolated by Fourier analysis. Main outcome measures were fERG amplitude (in µV) and phase (in degrees). The secondary outcome measure was visual acuity. Results: supplement was well tolerated by all patients throughout follow-up. After saffron, fERG amplitude was unchanged; after placebo, amplitude tended to decrease from baseline (mean change: −0.18 log µV, p < 0.05). Reverting the treatments, amplitude did not change significantly. fERG phase and visual acuity were unchanged throughout follow-up. Conclusions: short-term saffron supplementation was well tolerated and had no detrimental effects on the electroretinographic responses of the central retina and visual acuity. The current findings warrant further long-term clinical trials to assess the efficacy of saffron supplementation in slowing down the progression of central retinal dysfunction in ABCA4-related STG/FF. MDPI 2019-10-15 /pmc/articles/PMC6835540/ /pubmed/31618812 http://dx.doi.org/10.3390/nu11102461 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Piccardi, Marco Fadda, Antonello Martelli, Francesco Marangoni, Dario Magli, Adriano Minnella, Angelo M. Bertelli, Matteo Di Marco, Stefano Bisti, Silvia Falsini, Benedetto Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy |
title | Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy |
title_full | Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy |
title_fullStr | Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy |
title_full_unstemmed | Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy |
title_short | Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy |
title_sort | antioxidant saffron and central retinal function in abca4-related stargardt macular dystrophy |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835540/ https://www.ncbi.nlm.nih.gov/pubmed/31618812 http://dx.doi.org/10.3390/nu11102461 |
work_keys_str_mv | AT piccardimarco antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy AT faddaantonello antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy AT martellifrancesco antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy AT marangonidario antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy AT magliadriano antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy AT minnellaangelom antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy AT bertellimatteo antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy AT dimarcostefano antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy AT bistisilvia antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy AT falsinibenedetto antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy |